Latest close
$234.58
As of Oct 2, 2026
| Fund | Portfolio weight | Shares | Change vs prev. quarter |
|---|---|---|---|
| Tiger Global Management | 9.34% | 11,198,773 | TRIMMED (-6.8%) |
| Mairs & Power Funds | 8.64% | 4,707,792 | TRIMMED (-1.1%) |
| Polen Capital Management | 6.86% | 3,978,446 | TRIMMED (-3.1%) |
| Egerton Capital | 6.61% | 3,417,950 | ADDED (+27.8%) |
| H&H International Investment | 6.58% | 6,280,675 | TRIMMED (-54.6%) |
| Jensen Investment Management | 5.81% | 1,197,487 | TRIMMED (-26.6%) |
| Maverick Capital | 5.40% | 3,056,784 | TRIMMED (-3.7%) |
| Patient Capital Management | 4.65% | 709,587 | TRIMMED (-0.2%) |
| Appaloosa Management | 3.95% | 1,525,000 | ADDED (+3.6%) |
| Weitz Investment Management | 0.48% | 35,000 | HELD |
| Davis Advisors | 0.13% | 154,727 | ADDED (+36.3%) |
| Matrix Asset Advisors | 0.10% | 6,090 | TRIMMED (-22.5%) |
| Torray Funds | 0.08% | 2,938 | TRIMMED (-3.8%) |
| Century Management | 0.06% | 1,485 | TRIMMED (-4.8%) |
| Causeway Capital Management | 0.01% | 3,567 | TRIMMED (-0.6%) |
| Oakmark Funds | 0.00% | 12,475 | ADDED (+0.1%) |
| Dodge & Cox Funds | 0.00% | 3,400 | HELD |
| Pzena Investment Management | 0.00% | 1,445 | NEW |
Source: SEC Form 13F filings for the quarter ended Jun 30, 2026. Change labels compare each fund’s 2026 Q2 filing with its previous filing. 13F filings cover long positions only and arrive up to 45 days after quarter-end.
Exited this quarter: Third Point.
| Institutions holding | 5,939 of 8,857 filers |
| Long-only filers among them | 5,909 |
| Change vs 2026 Q1 | +197 net · 1,845 entered · 1,648 exited |
| Shares reported, all filers | 16,613,221,322 |
| Reported value, all filers | $3,373.2B |
Source: SEC Form 13F data sets — every filer's latest report for the quarter ended Jun 30, 2026, not just the tracked funds above; changes compare with the quarter ended Mar 31, 2026. Share counts and values are summed as reported in the filings (a small number of filers report values in thousands of dollars, so value totals are as-filed sums).
0 insiders bought on the open market in the last 90 days (0 purchases, $0), against 25 sales by 3 insiders ($967.6M).
Source: SEC Form 4 filings, as of Oct 3, 2026. Open-market transactions only.
5 House members reported buying (5 purchases vs 8 sales). Bought by Democrats and Republicans. Latest buy: Aug 18, 2026.
Source: U.S. House Clerk STOCK Act periodic transaction reports, as of Oct 3, 2026. Reported amounts are ranges, and reports can arrive up to 45 days after the trade. Senate reports are not included yet.
Politicians
· Bought by Members — Last 6 months: bought by a U.S. House member
· Bought by Both Parties — Last 6 months: bought by both Democratic and Republican members
· Bought by 3+ Members — Last 6 months: bought by 3 or more different members
Financial Screens
· Buffett — Companies with high ROE sustained for more than a decade
· Growth — Revenue up every year for 5 straight years
· Graham — Sound finances and a long run of profits
· O'Neil CAN SLIM — Explosive earnings growth leaders
· Gross Profitability (Novy-Marx) — High gross profit relative to total assets
Chart Signals
· Monthly Uptrend — Price above its 12-month moving average
· 52-Week High — Recently printed a new 52-week high
· Top Relative Strength — Top 20% of the universe by 6-month return
Red Flags
· Earnings Manipulation Suspect (Beneish) — Beneish M-Score above -1.78
· Excess Accruals (Sloan) — Sloan accruals ratio beyond ±25%
Key figures
· Buffett — Latest ROE: 76.3% · Years ROE ≥15% (of 10): 10 · 10-yr avg ROE: 45.6% · Latest net income: $120.1B
· Growth — Latest revenue: $215.9B · 5-yr revenue CAGR: 66.9% · Straight growth years: 11
· Graham — Current ratio: 3.91 · Straight profitable years: 16 · Debt ratio: 0.31 · Latest net income: $120.1B
· O'Neil CAN SLIM — 3-yr EPS growth: 206.6% · ROE: 76.3% · Latest revenue growth: 65.5%
· Gross Profitability (Novy-Marx) — Gross profit / assets: 74.2% · Gross margin: 71.1%
· Bought by Members — Members buying: 5 · Buy txns: 5 · Sell txns: 8 · Latest buy: Aug 18, 2026
· Bought by Both Parties — Members buying: 5 · Buy txns: 5 · Sell txns: 8 · Latest buy: Aug 18, 2026
· Bought by 3+ Members — Members buying: 5 · Buy txns: 5 · Sell txns: 8 · Latest buy: Aug 18, 2026
· Earnings Manipulation Suspect (Beneish) — M-Score: -1.16 · Receivables index: 1.01 · Margin deterioration: 1.06 · Sales growth index: 1.65 · Accruals ratio: 8.4%
· Excess Accruals (Sloan) — Accruals ratio: 33.6% · Net income: $120.1B · Operating cash flow: $102.7B · Investing cash flow: $-52.2B
Financial screens are computed from SEC company financial statements; red-flag models are screens, not verdicts — see Methodology.
· Super-investor 13F BEST — appeared in 9 of the last 20 quarterly lists; latest 2026 Q2, ranked #12 of 50.
· Politician BEST — appeared in 19 of the last 20 quarterly lists; latest 2026 Q2, ranked #7 of 50.
| 13F signal (2021 Q3 – 2026 Q1) | Events | Win rate | Avg return | SPY | Excess |
|---|---|---|---|---|---|
| Heavy accumulation — 3+ tracked funds increased together | 13 | 61.5% | +8.8% | +3.3% | +5.5% |
| Share count tripled (3x) | 5 | 80.0% | +13.5% | +5.1% | +8.3% |
| Heavy exit — 3+ tracked funds sold out together | 1 | 100.0% | +48.6% | +12.1% | +36.5% |
Measured from SEC 13F filings: entry at the close on the first trading day after each quarter’s filing deadline, exit one quarter later on the same rule, dividend-adjusted closes. Past records do not guarantee future results — see Track Record and Methodology.
Open this in the GetCoattail app →Live screens, charts and backtests for every tracked stock, fund and signal — free, no sign-up.